Laura Vecchione, MD Second Vice President & Medical Director, Gen Re Life Health

Come learn about the new and old prognostic and predictive factors, including the new molecular categorization of breast cancers with the triple negative subtype and the concept of targeted therapy. Discuss mortality patterns in early and advanced breast cancers and answer the question of sentinel lymph node biopsy – do microscopic metastases or isolated tumor cells affect the risk?